FR 171113
Latest Information Update: 18 Jul 2002
Price :
$50 *
At a glance
- Originator Fujisawa
- Class Antiplatelets; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis